Comparative Cost-Consequence Analysis of the Bivalent and Quadrivalent Vaccines Against HPV in Spain

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.489
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness Analysis of the Bivalent Compared With the Quadrivalent Human Papillomavirus Vaccines in Taiwan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Quadrivalent HPV Vaccine in Argentina: Cost-Effectiveness Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccines for Children

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Development of Vaccines and Gene Therapy Against HPV Infection and Cervical Cancer

2012English

An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model

PLoS ONE
Multidisciplinary
2015English

Prophylactic HPV Vaccines

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Influenza Surveillance in Western Turkey in the Era of Quadrivalent Vaccines: A 2003–2016 Retrospective Analysis

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Prs38 - Cost-Consequence Analysis of Fluticasone Furoate/Vilanterol for Asthma Management in Spain: An Analysis Based on the Salford Lung Study in Asthma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Risk of Miscarriage With Bivalent Vaccine Against Human Papillomavirus (HPV) Types 16 and 18: Pooled Analysis of Two Randomised Controlled Trials

BMJ
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy